Biopharmaceutical

Abeona Therapeutics

$2.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-8.93%) Today
-$0.03 (-1.47%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ABEO and other stocks, options, and ETFs commission-free!

About ABEO

Abeona Therapeutics Inc. Common Stock, also called Abeona Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY. The listed name for ABEO is Abeona Therapeutics Inc. Common Stock.

CEO
Joao Siffert, MD, MBA
Employees
88
Headquarters
New York, New York
Founded
1974
Market Cap
170.80M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.68M
High Today
$2.23
Low Today
$2.02
Open Price
$2.23
Volume
2.91M
52 Week High
$4.34
52 Week Low
$0.9895

Collections

ABEO Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 15, After Hours

You May Also Like

IDHD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure